However, platelet surface–associated CXCL14 correlated with the extent of platelet activation (CD62P) in patients with CAD, while plasma CXCL14 correlated with myocardial necrosis in patients with STEMI [6,7]. The gene discussed is CXCL14; the disease is coronary artery disorder.